BIOMARK SELECTED BY the Medical Alley and Investissement Quebec TO JOIN the US Go-to-Market Accelerator

biomark appoints dr jean francois haince as strategic advisor to guide its expansion into quebec

BIOMARK SELECTED BY THE MEDICAL ALLEY AND INVESTISSEMENT QUEBEC TO JOIN THE US GO-TO-MARKET ACCELERATOR Vancouver, British Columbia – (September 1, 2022) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an oncology-focused company with advanced near-to-market liquid biopsy diagnostic technologies is pleased to announce today that its Quebec-based wholly-owned subsidiary BioMark Diagnostic […]

3 Cancer Diagnostic Stocks To Watch Following Roche’s GenMark Buy

3 cancer diagnostic stocks to watch following roche genmark buy

Biotech companies are showing leadership in early detection of cancer. March 16, 2021 Melanie Schaffer , Benzinga Staff Writer  In January, Exact Sciences Corporation EXAS 1.59% announced it completed its acquisition of Thrive Earlier Detection Corp. and got Thrive’s blood-based multi-cancer detection technology.   Why It Matters: Early detection of cancer greatly increases the survival rate and smaller biotech companies are showing leadership skills in […]

Doctors fear an impending wave of cancer patients after COVID-19 delays

doctors fear an impending wave of cancer patients after covid 19 delays

BY MORGAN LOWRIE, THE CANADIAN PRESS Posted Feb 4, 2021 10:24 am PST MONTREAL, Italy — While the prospectof mass vaccination has raised hopes of the COVID-19 crisis soon waning, oncologists and cancer researchers say one of its grim legacies may be a lingering increase in cancer mortality rates. The pandemic caused a “dramatic” drop in […]

BioMark Diagnostics Announces Peer Reviewed Publication on Detection of Cancer

biomark announces peer reviewed publication on detection of cancer

Vancouver, British Columbia – (June 23 , 2020) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), a developer of proprietary, non-invasive, and accurate cancer diagnostic solutions to assist in detecting, monitoring and assessing treatment for cancer early and cost effectively, announced today a peer reviewed scientific publication to support its innovative cancer […]

BioMark Diagnostics Forms New Company, Bio Stream Diagnostics Inc., for ‘30-Second’ COVID-19 Screening

biostream 30 second covid 19 screening

Rapid COVID-19 testing will use machine learning and advanced Raman spectroscopy to provide low-cost, accurate results Vancouver, British Columbia – (June  10 , 2020) – – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), a  developer of proprietary, non-invasive, and accurate diagnostic solutions which can help detect, monitor and assess cancer early and […]

WHO outlines steps to save 7 million lives from cancer

who outlines steps to save 7 million lives from cancer

4 February 2020 News release Geneva, Switzerland The World Health Organization (WHO) today spells out the need to step up cancer services in low and middle-income countries. WHO warns that, if current trends continue, the world will see a 60% increase in cancer cases over the next two decades. The greatest increase (an estimated 81%) in new […]

About Glioblastoma (GBM)

about glioblastoma gbm

Overview Tumour Group: Gliomas WHO Grade: Grade IV Prevalence/Incidence: The incidence of glioblastoma multiforme (GBM) is 2 to 3 per 100,000 people in the United States and Europe. GBM accounts for 12 to 15% of all intracranial tumours and 50 to 60 per cent of astrocytic tumours. GBMs increase in frequency with age, and affect […]

Lung Cancer Screening in Real World Has High False-Positive Rate

lung cancer screening in real world has high false positive rate

By Kelly YoungEdited by: David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD A pair of studies in JAMA Internal Medicine illustrate the difficulties of implementing lung cancer screening. In the first, eight Veterans Health Administration medical centers identified and screened patients using low-dose computed tomography (LDCT). Over 2100 patients who were eligible for screening based […]